HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Spectral-domain optical coherence tomography of combined hamartoma of the retina and retinal pigment epithelium in neurofibromatosis.

Abstract
A 5-year-old girl was diagnosed with neurofibromatosis type 2 (NF-2) due to multiple neurofibromas, cafe-au-lait spots, and schwannomas of the brain. During ophthalmologic evaluation, a posterior subcapsular cataract and a gray-green colored subretinal lesion were found in right eye. Fluorescein angiography (FA) revealed a combined hamartoma of the retina and retinal pigment epithelium (CHRRPE). At age 9, she underwent cataract surgery. At this time FA and spectral-domain optical coherence tomography (SD-OCT) were taken. The SD-OCT showed an elevated hyperreflective mass in the retina with prominent attenuation of the inner and outer retina, but minimal attenuation in the photoreceptor layers. The underlying retina appeared to be disorganized and thick (791 µm). This is the first case report of SD-OCT imaging of a CHRRPE associated with NF-2 in a pediatric patient. By using SD-OCT in this patient, we could obtain detailed tumor characteristics, and SD-OCT may be helpful in the diagnosis and management of CHRRPE.
AuthorsHae Min Kang, Hyoung Jun Koh, Eun Jee Chung
JournalKorean journal of ophthalmology : KJO (Korean J Ophthalmol) Vol. 27 Issue 1 Pg. 68-71 (Feb 2013) ISSN: 2092-9382 [Electronic] Korea (South)
PMID23372386 (Publication Type: Case Reports, Journal Article)
Topics
  • Child, Preschool
  • Diagnosis, Differential
  • Female
  • Hamartoma (complications, diagnosis)
  • Humans
  • Neurofibromatosis 2 (complications, diagnosis)
  • Retinal Diseases (complications, diagnosis)
  • Retinal Pigment Epithelium (pathology)
  • Tomography, Optical Coherence (methods)
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: